Back to Stakeholders
HospitalsIndependent Academic Research Groups

Medical University Innsbruck

Austria
4 Trials

Leading Austrian medical university in Innsbruck. Researchers here have investigated the structural biology of psilocybin-biosynthesizing enzymes with the aim of optimizing sustainable psilocybin production, while also contributing to clinical research as European psychedelic frameworks evolve.

Quick Facts

Type
Other
HQ
Austria
Website
Visit

Sponsored Trials

2
CompletedNA

Esketamine Treatment for Depressive Episodes With Suicidal Ideation in Mood Disorders

Start Date
Compounds
Esketamine, Placebo
WithdrawnIII

ECT vs. Esketamine

Start Date
Compounds
Esketamine

Collaborated Trials

2
CompletedNA

Low-dose S-Ketamine and Postpartum Depression in Parturients With Prenatal Depression

Start Date
Compounds
Esketamine, Placebo
CompletedNA

Low-dose S-ketamine in Women With Prenatal Depression

Start Date
Compounds
Ketamine, Placebo